Expression of BAG-1 and BcL-2 Proteins Before and After Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer

References

• Reed J. C. Dysregulation of apoptosis in cancer. J. Clin. Oncol. 1999; 17: 2941–2953, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Adams J. D., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281(5381)1322–1326, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 1997; 3(6)614–620, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zou H., Henzel W. J., Liu X., Lutschg A. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997; 90(3)405–413, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Takayama S., Sato T., Krajewski S. Cloning and functional analysis of BAG-1: a novel bcl-2-binding protein with anti-cell death activity. Cell 1995; 80: 279–284, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Takayama S., Bimston D. N., Matsuzawa S. BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO J. 1997; 16: 4887–4896, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bardelli A., Longati P., Albero D. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J. 1996; 15: 6205–6212, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Zeinet M., Gehring U. A protein that interacts with members of the nuclear hormone receptor family: identification and cDNA cloning. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 11465–11469, [CSA]
   PubMed Web of Science ®Google Scholar
• Froesch B. A., Takayama S., Reed J. C. BAG-1L protein enhances androgen receptor function. J. Biol. Chem. 1998; 273: 11660–11666, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Yang X., Chernenko G., Hao Y. Human BAG-1/RAP46 is expressed as four isoforms by alternative translation initiation and overexpressed in human cancers. Oncogene 1998; 16: 981–989, [CROSSREF]
   Google Scholar
• Reed J. C. Balancing cell life and death: bax, apoptosis, and breast cancer. J. Clin. Invest. 1996; 97: 2403–2404, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Schorr K., Li M., Krajewski S., et al. Bcl-2 gene family and related proteins in mammary galand involution and breast cancer. J. Mammary Gland Biol. Neoplasia 1999; 4: 153–164, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• van Slooten H. J., Clahsen P. C., van Dierendonck J. H. Expression of Bcl-2 in node–negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy. Br. J. Cancer 1996; 74(1)78–85, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Makris A., Powles T. J., Dowsett M. Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas. Clin. Cancer Res. 1997; 3(4)593–600, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Frassoldati A., Adami F., Banzi C. Changes of biological features in breast cancer cells determined by primary chemotherapy. Breast Cancer Res. Treat. 1997; 44: 185–192, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ellis P. A., Smith I. E., Detre S. Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy. Breast Cancer Res. Treat. 1998; 48(2)107–116, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bonetti A., Zaninelli M., Leone R. Bcl-2 but not p53 expression is associated with resistance to chemotherapy in advanced breast cancer. Clin. Cancer Res. 1998; 4: 2331–2336, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Yang X., Hao Y., Ding Z., et al. Differential expression of antiapoptotic gene BAG-1 in human breast normal and cancer cell lines and tissues. Clin. Cancer Res. 1999; 5: 1816–1822, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Tumer B. C., Krajewski S., Krajewska M. BAG-1: a novel biomarker predicting long-term survival in early stage breast cancer. Breast Cancer Res. Treat. 1999; 57(1)26, (Abst. 6)
   Google Scholar
• Tang S. C., Shaheta N., Chernenko G. Expression of BAG-1 in invasive breast carcinomas. J. Clin. Oncol. 1999; 17(6)1710–1719, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Brimmell M., Burns J. S., Munson P. High level expression of differentially localized BAG-1 isoforms in some estrogen receptor–positive human breast cancers. Br. J. Cancer 1999; 81(6)1042–1051, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Takayama S., Krajewski S., Krajewska M., et al. Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res. 1998; 58: 3116–3136, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Zapata J. M., Krajewska M., Krajewski S. Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors. Breast Cancer Res. Treat. 1998; 47(2)129–140, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pusztai L., Siddik Z. H., Mills G. B., Bast R. C., Jr. Physiologic and pathologic drug resistance in ovarian carcinoma: a hypothesis based on a clonal progression model. Acta Oncol. 1998; 37: 629–640, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pusztai L., Hortobagyi G. N. High dose chemotherapy. How resistant is breast cancer?. Drug Resist. Updat. 1998; 1: 62–72
   PubMed Web of Science ®Google Scholar
• Daidone M. G., Silvestrini R., Luisi A. Changes in biological markers after primary chemotherapy for breast cancers. Int. J. Cancer 1995; 61(3)301–305, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chang J., Powles D., Allred S. E., et al. Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. J. Clin. Oncol. 1999; 17: 3058–3063, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar